These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8120870)

  • 1. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols.
    Pearce BC; Parker RA; Deason ME; Dischino DD; Gillespie E; Qureshi AA; Volk K; Wright JJ
    J Med Chem; 1994 Feb; 37(4):526-41. PubMed ID: 8120870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocholesterolemic activity of synthetic and natural tocotrienols.
    Pearce BC; Parker RA; Deason ME; Qureshi AA; Wright JJ
    J Med Chem; 1992 Oct; 35(20):3595-606. PubMed ID: 1433170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties.
    Qureshi AA; Mo H; Packer L; Peterson DM
    J Agric Food Chem; 2000 Aug; 48(8):3130-40. PubMed ID: 10956081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Leonard DA
    Crit Rev Biochem Mol Biol; 1999; 34(2):123-40. PubMed ID: 10333389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling.
    Packer L; Weber SU; Rimbach G
    J Nutr; 2001 Feb; 131(2):369S-73S. PubMed ID: 11160563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens.
    Qureshi AA; Peterson DM
    Atherosclerosis; 2001 May; 156(1):39-47. PubMed ID: 11368995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some 3-hydroxy-5-aminopentanoic acid derivatives.
    Carganico G; Cangiano G; Cozzi P; Lovisolo PP
    Farmaco Sci; 1987 Apr; 42(4):277-84. PubMed ID: 3595839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocholesterolemic and antioxidant properties of 3-(4-hydroxyl)propanoic acid derivatives in high-cholesterol fed rats.
    Lee MK; Park YB; Moon SS; Bok SH; Kim DJ; Ha TY; Jeong TS; Jeong KS; Choi MS
    Chem Biol Interact; 2007 Oct; 170(1):9-19. PubMed ID: 17662703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of either gamma-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters.
    Raederstorff D; Elste V; Aebischer C; Weber P
    Ann Nutr Metab; 2002; 46(1):17-23. PubMed ID: 11914511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant activity of tocopherols, tocotrienols, and gamma-oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2'-azobis(2-methylpropionamidine) dihydrochloride.
    Xu Z; Hua N; Godber JS
    J Agric Food Chem; 2001 Apr; 49(4):2077-81. PubMed ID: 11308370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis.
    Karanewsky DS; Badia MC; Ciosek CP; Robl JA; Sofia MJ; Simpkins LM; DeLange B; Harrity TW; Biller SA; Gordon EM
    J Med Chem; 1990 Nov; 33(11):2952-6. PubMed ID: 2231594
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
    Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
    Chrysselis MC; Rekka EA; Kourounakis PN
    J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
    Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
    Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
    Tooulia KK; Theodosis-Nobelos P; Rekka EA
    Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine.
    Chen L; Haught WH; Yang B; Saldeen TG; Parathasarathy S; Mehta JL
    J Am Coll Cardiol; 1997 Aug; 30(2):569-75. PubMed ID: 9247534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice.
    Chung MJ; Sung NJ; Park CS; Kweon DK; Mantovani A; Moon TW; Lee SJ; Park KH
    Eur J Pharmacol; 2008 Jan; 578(2-3):159-70. PubMed ID: 17976573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.